Cellebrite DI Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Cellebrite DI Ltd. (CLBT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-283.01-81.10120.8171.405.78
Depreciation & Amortization10.618.919.197.015.88
Deferred Income Tax-4.025.13-2.39-1.640.00
Stock Based Compensation30.5819.0013.716.487.27
Change in Working Capital42.0572.62-1.5320.6749.71
Change in Accounts Receivable-5.832.27-12.89-1.96-19.73
Change in Inventory0.980.24-3.68-1.80-0.69
Change in Accounts Payable2.764.43-14.329.35-1.43
Change in Other Working Capital21.8277.51-81.08-55.9123.83
Other Operating Activities334.8548.71-105.50-61.39-2.13
Net Cash from Operating Activities132.17102.0620.5836.0566.51
Investing Activities
Capital Expenditures-8.577.92-9.09-8.11-6.18
Acquisitions-2.750.000.00-20.00-15.05
Purchases of Investments-136.12-144.32-165.36-21.0014.78
Sales/Maturities of Investments-2.04-144.3283.2294.340.00
Other Investing Activities-2.04129.700.000.000.00
Net Cash from Investing Activities-149.47-22.54-91.2345.23-6.45
Financing Activities
Common Stock Issued20.662.6213.972.311.49
Common Stock Repurchased0.000.000.000.00-0.09
Dividends Paid0.000.000.00-100.000.00
Other Financing Activities-0.0119.140.0029.300.00
Net Cash from Financing Activities20.6521.7713.97-68.40-8.59
Summary
Effect of Forex Changes on Cash-1.210.59-1.64-0.750.00
Net Change in Cash2.14101.28-56.6812.8852.16
Cash at Beginning of Period189.5287.65145.97133.850.00
Cash at End of Period191.66189.5287.65145.970.00
Free Cash Flow123.6194.1420.5836.0560.33
Supplemental Disclosures
Income Taxes Paid7.719.059.058.162.91